Table of Content


1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Analgesics Market
5.1 Market Performance
5.2 Market Breakup by Type
5.3 Market Breakup by Drug Class
5.4 Market Breakup by Route of Administration
5.5 Market Breakup by Pain Type
5.6 Market Breakup by Application
5.7 Market Breakup by Region
5.8 Market Forecast

6 North America Analgesics Market
6.1 Market Performance
6.2 Impact of COVID-19
6.3 Market Forecast

7 North America Analgesics Market: Breakup by Type
7.1 Prescription Analgesics
7.2 OTC Analgesics

8 North America Analgesics Market: Breakup by Drug Class
8.1 Opioids
8.2 NSAID
8.3 Others

9 North America Analgesics Market: Breakup by Route of Administration
9.1 Oral
9.2 Parenteral
9.3 Topical
9.4 Transdermal
9.5 Rectal

10 North America Analgesics Market: Breakup by Pain Type
10.1 Musculoskeletal Pain
10.2 Surgical and Trauma Pain
10.3 Cancer Pain
10.4 Neuropathic Pain
10.5 Migraine
10.6 Obstetrical Pain
10.7 Fibromyalgia
10.8 Pain due to Burns
10.9 Dental/Facial Pain
10.10 Pediatric Pain
10.11 Others

11 North America Analgesics Market: Breakup by Application
11.1 Internal Analgesics
11.2 External Analgesics

12 North America Analgesics Market: Breakup by Country
12.1 United States
12.1.1 Historical market Trends
12.1.2 Market Breakup by Type
12.1.3 Market Breakup by Drug Class
12.1.4 Market Breakup by Route of Administration
12.1.5 Market Breakup by Pain Type
12.1.6 Market Breakup by Application
12.1.7 Market Forecast
12.2 Canada
12.2.1 Historical market Trends
12.2.2 Market Breakup by Type
12.2.3 Market Breakup by Drug Class
12.2.4 Market Breakup by Route of Administration
12.2.5 Market Breakup by Pain Type
12.2.6 Market Breakup by Application
12.2.7 Market Forecast
12.3 Mexico
12.3.1 Historical market Trends
12.3.2 Market Breakup by Type
12.3.3 Market Breakup by Drug Class
12.3.4 Market Breakup by Route of Administration
12.3.5 Market Breakup by Pain Type
12.3.6 Market Breakup by Application
12.3.7 Market Forecast

13 SWOT Analysis
13.1 Overview
13.2 Strengths
13.3 Weaknesses
13.4 Opportunities
13.5 Threats

14 Value Chain Analysis
14.1 Overview
14.2 Research and Development
14.3 Raw Material Procurement
14.4 Manufacturing
14.5 Marketing
14.6 Distribution
14.7 End-Use

15 Porter’s Five Forces Analysis
15.1 Overview
15.2 Bargaining Power of Buyers
15.3 Bargaining Power of Suppliers
15.4 Degree of Rivalry
15.5 Threat of New Entrants
15.6 Threat of Substitutes

16 Price Analysis

17 Competitive Landscape
17.1 Market Structure
17.2 Key Players
17.3 Profiles of Key Players